Measles and Rubella monitoring, June 2013
Measles and rubella are targeted for elimination in Europe by 2015. ECDC closely monitors progress towards interruption of endemic transmission of both diseases through enhanced surveillance and epidemic intelligence. Measles and rubella vaccinations are routinely delivered as trivalent measles-mumps-rubella (MMR) vaccine in Europe, and the first of the two recommended doses is normally given during the second year of life.
Influenza virus characterisation, December 2019
16 Jan 2020 - This is the third report for the 2019–20 influenza season. As of week 1/2020, 42 844 influenza detections had been reported across the WHO European Region; 85% type A viruses, with A(H3N2) prevailing over A(H1N1)pdm09, and 15% type B viruses, with 531 (92%) of 576 ascribed to a B/Victoria lineage.
Monthly measles and rubella monitoring report, January 2020
10 Jan 2020 - The monitoring report is based on measles and rubella data from The European Surveillance System (TESSy) for the period 1 December 2018 to 30 November 2019.